BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6698965)

  • 1. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.
    Nakajima M; Irimura T; Di Ferrante N; Nicolson GL
    J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity.
    Nakajima M; Irimura T; Nicolson GL
    Anal Biochem; 1986 Aug; 157(1):162-71. PubMed ID: 3766958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
    Nakajima M; Irimura T; Nicolson GL
    Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
    Bashkin P; Razin E; Eldor A; Vlodavsky I
    Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelet heparanase: purification, characterization and catalytic activity.
    Freeman C; Parish CR
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid quantitative assay for the detection of mammalian heparanase activity.
    Freeman C; Parish CR
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):229-37. PubMed ID: 9224651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of extracellular matrix-associated glycosaminoglycans produced by untransformed and transformed bovine corneal endothelial cells in culture.
    Wang ZW; Irimura T; Nakajima M; Belloni PN; Nicolson GL
    Eur J Biochem; 1985 Nov; 153(1):125-30. PubMed ID: 2998789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; Nicolson GL
    Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
    Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-speed gel-permeation chromatography of glycosaminoglycans: its application to the analysis of heparan sulfate of embryonic carcinoma and its degradation products by tumor cell-derived heparanase.
    Irimura T; Nakajima M; Di Ferrante N; Nicolson GL
    Anal Biochem; 1983 Apr; 130(2):461-8. PubMed ID: 6223541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.